2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
Before 2000
Books

Publication History

Blum JS, Weller C, Booth CJ, Babar IA, Liang X, Slack FJ, and Saltzman WM. Topical treatment of K-ras and Pten mediated intravaginal cancer with camptothecin-loaded nanoparticles, Drug Delivery and Translational Research 1:383-394 (2011).
Liu J, Jiang Z, Zhang SM, Liu C, Gross RA, Kyriakides TR, and Saltzman WM. Biodegradation, biocompatibility, and drug delivery in poly(omega-pentadecalactone-co-p-dioxanone) copolyesters, Biomaterials 32: 6646-6654 (2011).
McNeer Nicole Ali, Schleifman EB, Glazer PM, Saltzman WM. Polymer delivery systems for site-specific genome editing. J Control Release. 2011 May 18. [Epub ahead of print]
Hibino N, Villalona G, Pietris N, Duncan DR, Schoffner A, Roh JD, Yi T, Dobrucki W, Mejias D, Sawh-Martinez R., Harrington J, Sinusas A, Krause DS, Kyriakides T, Saltzman WM, Pober JS, Shin’oka T, and Breuer CK. Tissue engineered vascular grafts form neovessels that arise from regeneration of the adjacent blood vessel, FASEB Journal, published ahead of print May 12, 2011, doi:10.1096/fj.11-182246.
Cheng CJ and Saltzman WM. Enhanced siRNA delivery into cells by exploiting the synergy between targeting ligands and cell-penetrating peptides, Biomaterials 32:6194-6203 (2011). [PMCID: in process]
Park J, Mattessich T, Jay SM, Agawu A, Saltzman WM, and Fahmy TM. Enhancement of surface ligand display on PLGA nanoparticles with amphiphilic ligand conjugates. Journal of Controlled Release, in press.
Sawyer AJ, Saucier-Sawyer J, Booth C, Liu J, Patel T, Piepmeier JM, and Saltzman WM. Convection-enhanced delivery of camptothecin-loaded polymer nanoparticles for treatment of intracranial tumors, Drug Delivery and Translational Research 1:34-42 (2011). [PMCID: in process]
Liu J, Jiang Z, Zhou J, Zhang S, and Saltzman WM. Enzymatic synthesized poly(amine-co-esters) as non-viral vectors for gene delivery, Journal of Biomedical Materials Research A 96A:456-465 (2011). PMCID: PMC3080021
McNeer, NA, Chin JY, Schleifman EB, Fields RJ, Glazer PM, and Saltzman WM. Nanoparticles deliver triplex-forming PNA for site-specific genomic recombination in CD34+ human hematopoietic progenitors. Molecular Therapy 19:172-180 (2011). PMCID: PMC3017438
Prasad S, Cody V, Saucier-Sawyer JK, Saltzman WM, Sasaki CT, Edelson RL, Birchall MA, Hanlon DJ. Polymer nanoparticles containing tumor lysates as antigen delivery vehicles for dendritic cell-based anti-tumor immunotherapy. Nanomedicine 7:1-10 (2011). PMCID: PMC3073408

Kuo-Haller P, Cu Y, Blum J, Appleton JA, and Saltzman WM. Vaccine delivery by polymeric vehicles in the mouse reproductive tract induce sustained local and systemic immunity, Molecular Pharmaceutics 7:1585-1595 (2010). PMCID: PMC3004023
Roh JD, Sawh-Martinez R, Brennan MP, Jay SM, Devine L, Rao DA, Yi T, Mirensky TL, Nalbandian A, Udelsman B, Hibino N, Shinoka T, Saltzman WM, Snyder E, Kyriakides TR, Pober JS, Breuer CK. Tissue-engineered vascular grafts transform into mature blood vessel via an inflammation-mediated process of vascular remodeling. Proceedings of the National Academy of Sciences, 107:4669-74 (2010). PMCID: PMC2842056
Rubin J, Paltiel AD, and Saltzman WM. Are we studying what matters? Health priorities and NIH-funded biomedical engineering research. Annals of Biomedical Engineering 38:2237-2251 (2010). PMID: 20225125 [PMCID: in process]
Lo CT, Van Tassel PR, and Saltzman WM. Poly(lactide-co-glycolide) nanoparticle assembly for highly efficient delivery of potent therapeutic agents from medical devices, Biomaterials 31: 3631-3642 (2010). PMCID: PMC2837119
Jay SM, Shepherd BR, Andrejecsk JW, Kyriakides TR, Pober JS, and Saltzman WM. Dual delivery of VEGF and MCP-1 to support endothelial cell transplantation for therapeutic vascularization, Biomaterials 31:3054-3062 (2010). PMCID: PMC2827647
Sirianni RW, Olausson P, Chiu AS, Taylor JR, and Saltzman WM. The behavioral and biochemical effects of BDNF containing polymers implanted in the hippocampus of rats. Brain Research 1321:40-50 (2010). PMCID: PMC2834850
Sirianni R, Jang EH, Miller KM, and Saltzman WM. Parameter estimation methodology in a model of hydrophobic drug release from a polymer coating, Journal of Controlled Release 142:474-482 (2010). PMID: 19958804
Cartiera MS, Ferreira EC, Caputa C, Egan ME, Caplan MJ, and Saltzman WM. Partial correction of cystic fibrosis defects with PLGA nanoparticles encapsulating curcumin, Molecular Pharmaceutics 7: 86-93 (2010). PMCID: PMC2815009
Cu Y, Lemoellic C, Caplan MJ, and Saltzman WM. Ligand-modified gene carriers increase uptake in target cells but reduce DNA release and transfection efficiency, Nanomedicine 6:334-343 (2010). PMCID: PMC2847641

Liu J, Jiang Z, Zhang S, and Saltzman WM. Poly(ω-pentadecalactone-co-butylene-co-succinate) nanoparticles as biodegradable carriers for camptothecin delivery, Biomaterials 30:5707-5719 (2009). PMCID: PMC2774808
Lo CT, Van Tassel PR, and Saltzman WM. Simultaneous Release of Multiple Compounds from Mixed Nanoparticles Adsorbed to the Surface of an Implantable Medical Device, Biomaterials 30:4889-4897 (2009). PMCID: PMC2742909
Demento SL, Eisenbart SC, Foellmer HG, Platt C, Caplan MJ, Saltzman WM, Mellman I, Ledizet M, Fikrig E, Flavell RA, and Fahmy TM. Inflammasome-activating nanoparticles as modular systems for optimizing vaccine efficacy, Vaccine 27:3013-3021 (2009). PMCID: PMC2695996
Bennewitz M and Saltzman WM. Nanotechnology for delivery of drugs to the brain for epilepsy, Neurotherapeutics 6(2):323-336 (2009). PMCID: PMC2673491
Woodrow KA, Cu Y, Booth CJ, Saucier-Sawyer J, Wood MJ, and Saltzman WM. Intravaginal gene silencing using biodegradable nanoparticles densely loaded with small-interfering RNA, Nature Materials 8:526-533 (2009). PMCID: PMC2693358
Park J, Fong PM, Lu J, Booth CJ, Russell KS, Saltzman WM, Fahmy TM. PEGylated PLGA nanoparticles for controlled delivery of doxorubicin, Nanomedicine 5:410-418 (2009). PMCID: PMC2789916
Cartiera MS, Johnson KM, Rajendran V, Caplan MJ, and Saltzman WM. The uptake and intracellular fate of PLGA nanoparticles in epithelial cells, Biomaterials 30:2790-2798 (2009). PMID: 19232712 [PMCID: in process]
Cu Y and Saltzman WM. Mathematical modeling of molecular diffusion through mucus Advanced Drug Delivery Reviews, 61:101-114 (2009). PMCID: PMC2646819
Jay SM and Saltzman WM. Controlled Delivery of VEGF Via Modulation of Alginate Microparticle Ionic Crosslinking. Journal of Controlled Release 134:26-34 (2009). PMCID: PMC2678414
Woodrow KA, Wood MJ, Saucier-Sawyer JK, Solbrig C, and Saltzman WM. Biodegradable meshes printed with extracellular matrix proteins support micropatterned hepatocyte cultures, Tissue Engineering 15:1169-79 (2009). PMCID: PMC2792091
Shepherd BR, SM Jay, WM Saltzman, G Tellides, and JS Pober, Human aortic smooth muscle cells promote arteriole formation by co-engrafted endothelial cells, Tissue Engineering 15:165-173 (2009). PMCID: PMC2679183
Cu Y and Saltzman WM. Controlled surface modification with poly(ethylene glycol) enhances diffusion of PLGA nanoparticles in human cervical mucus. Molecular Pharmaceutics 6:173-181 (2009). PMCID: PMC2637413

Sirianni R, Kremer J, Chen Y-L, Keeley F,and Saltzman WM. Local delivery of paclitaxel to heterogeneous tissue: the impact of extracellular matrix components. Biomacromolecules 9:2792-2798 (2008). PMID: 18785771
Nelson GN, Roh JD, Mirensky TL, Wang Y, Yi T, Tellides G, Pober JS, Shkarin P, Shapiro EM, Saltzman WM, Papademetris X, Fahmy TM, and Breuer CK. Initial evaluation of the use of USPIO cell labeling and noninvasive MR monitoring of human tissue-engineered vascular grafts in vivo. FASEB Journal 22:3888-3895 (2008). PMCID: PMC2574029
Wittmer CR, Phelps JA, Lepus CM, Saltzman WM, Harding MJ, Van Tassel PR. Multilayer nanofilms as substrates for hepatocellular applications, Biomaterials 29:4082-4090 (2008). PMCID: PMC2637394
Kobsa S and Saltzman WM. Bioengineering approaches to controlled protein delivery, Pediatric Research 63:513-519 (2008). PMID: 18427296
Fahmy TM, Demento SL, Caplan M, Mellman I, and Saltzman WM. Design opportunities and challenges for nanoparticle vaccines, Nanomedicine 3:343-355 (2008). PMID: 18510429
Jay SM, BR Shepherd, JP Bertram, JS Pober, and WM Saltzman, Engineering of multifunctional gels integrating highly efficient growth factor delivery with endothelial cell transplantation, FASEB Journal 22:2949-2956 (2008). PMCID: PMC2493461
Blum JS and Saltzman WM. High Loading Efficiency and Tunable Release of Plasmid DNA Encapsulated in Submicron Particles Fabricated from PLGA Conjugated with Poly-L-lysine, Journal of Controlled Release 129:66-72 (2008). PMCID: PMC2494593
Roh JD, Nelson GN, Brennan MP, Mirensky TL, Yi T, Hazlet TF, Tellides G, Sinusas AJ, Pober JS, Saltzman WM, Kyriakides TR, Breuer CK. Small –diameter biodegradable scaffolds for functional vascular tissue engineering in the mouse model. Biomaterials. 29(10):1454-63 (2008). PMCID: PMC2375856
Zhang Q, Cuartas E, Mehta N, Gilligan J, Ke D, Saltzman WM, Kotas M, Ma M, Rajan S, and Vignery A. Replacement of bone marrow by bone in rat femurs: the bone bioreactor. Tissue Engineering 14:237-246 (2008). PMID: 18333776

Haverstick K, Fleming A, and Saltzman WM. Conjugation to Increase the Treatment Volume during Local Therapy: A Case Study with PEGylated Camptothecin, Bioconjugate Chemistry 18: 2115-2121 (2007).
Roh JD, Brenan MP, Udelsman BV, Lockhart B, Fong PM, Lopez-Soler RI, Saltzman WM, and Breuer CK. Centrifugal seeding increases seeding efficiency, cellular distribution, and collagen production of bone marrow stromal cells in porous biodegradable scaffolds. Tissue Engineering 13:2743-9 (2007). PMID: 17880269
Fong PM, Goyal A, Brennan MP, Park J, Moss RL, Saltzman WM, Breuer CK. Development of PTH eluting microspheres for the treatment of hypoparathyroidism. Journal of Surgical Research 143:195-197 (2007). PMID: 17720197
Neeves KB, Sawyer A, Foley CP, Saltzman WM, and Olbricht WL. Dilation and degradation of the brain extracellular matrix enhance penetration of infused polymer nanoparticles, Brain Research 1180:121-132 (2007). PMCID: PMC2169304
Saltzman WM and Kyriakides. Cell interactions with polymers In Textbook of Tissue Engineering, 3rd edition, RP Lanza, R Langer, J Vacanti (Ed.), Academic Press, NY, p. 279-292 (2007).
Fahmy TM, Fong PM, Park J, Constable T, Saltzman WM. Nanosystems for simultaneous imaging and drug delivery to T cells, The AAPS Journal 9:E171-E180 (2007). PMCID: PMC2751406
Sawyer AJ, Piepmeier JM, Saltzman WM. New methods for direct delivery of chemotherapy for treating brain tumors. Yale J Biol Med 79: 141-152 (2007). PMCID: PMC1994797
Ying V, Haverstick K, Page RL, Saltzman WM. Efficacy of camptothecin and polymer-conjugated camptothecin in tumor spheroids and implanted tumors, Journal of Biomaterials Science 18:1283-1299 (2007). PMID: 17939886
Fahmy TM, Schneck J, and Saltzman WM. A nanoscopic multivalent T cell antigen-presenting carrier: An approach for sensitive detection and drug delivery, Nanomedicine 3:75-85 (2007). PMID: 17379171
Solbrig CM, Saucier-Sawyer JK, Cody V, Saltzman WM, and Hanlon DJ. Polymer microparticles for immunotherapy from encapsulated tumor-associated antigens and whole tumor cells, Molecular Pharmaceutics 4: 47-57 (2007). PMID: 17217312
Wittmer CR, Phelps JA, Saltzman WM, and Van Tassel PR. Fibronectin terminated multilayer films: protein adsorption and cell attachment studies Biomaterials 28 (5):851-860 (2007). PMCID: PMC1773012

Li H., Tran VV, Hu Y, Saltzman WM, Barnstable CJ, and Tombrin-Tink J. A PEDF peptide encapsulated in controlled release poly(lactide-co-glycolide) microspheres protects retinal ganglion cells from transient ischemic injury, Experimental Eye Research 83 (4): 824-833 (2006).
Keegan ME, Royce SM, Fahmy T, and Saltzman WM. In vitro evaluation of biodegradable microspheres with surface-bound ligands, Journal of Controlled Release 110: 574-580 (2006). PMID: 16386325
Neeves KB, Lo CT, Foley CP, Saltzman WM, and Olbricht WL. Fabrication and characterization of microfluidic probes for convection enhanced drug delivery. Journal of Controlled Release 111:252-262 (2006). PMID: 16476500
Shen H, Hu YY, and Saltzman WM. DNA Diffusion in Mucus: effect of size, topology and charge of DNAs, Biophysical Journal 91:639-644 (2006). PMCID: PMC1483105
Mahoney M, Krewson C, Miller J, Saltzman WM. Impact of cell type and density on NGF distribution and bioactivity in three-dimensional collagen gel cultures. Tissue Engineering 12:1915-1927 (2006). PMID: 16889521
Saltzman M and Desai T. Drug delivery in the BME curricula. Annals of Biomedical Engineering 34:270-275 (2006).
Goyal A, Wang Y, Su H, Dobrucki LW, Brennan M, Fong P, Dardik A, Tellides G, Sinuses A, Pober J, Saltzman WM, Breuer CK. Development of a Model System for Preliminary Evaluation of Tissue Engineered Vascular Conduits. Journal of Pediatric Surgery 41:787-791 (2006). PMID: 16567194
Sheardown H and Saltzman WM. Novel drug delivery systems for posterior segment ocular disease, in Ocular Angiogenesis, Barnstable C and Tombrin-Tink J (Ed.), 393-408 (2006).
Keegan ME and Saltzman WM. Surface modified biodegradable microspheres for DNA vaccine delivery, in DNA Vaccines, Saltzman, Brandsma, Shen (Ed), (2006). Also Methods in Molecular Medicine 127:107-113 (2006). PMID: 16988450

Shen H, Ackerman AL, Cody V, Cresswell P, Edelson RL, Saltzman WM, and Hanlon DJ. Enhanced and prolonged cross-presentation following endosomal escape of exogenous antigens encapsulated in biodegradable nanoparticles, Immunology 117:78-88 (2005). PMCID: PMC1782199
Anthony T, Fong P, Goyal A, Saltzman WM, Moss RL, and Breuer C. Parathyroid hormone controlled release systems for surgical treatment for hypoparathyroidism, Journal of Pediatric Surgery, 40: 81-85 (2005). PMID: 15868563
Fahmy TM, Fong PM, Goyal A, and Saltzman WM. Targeted nanoparticles for drug delivery, Materials Today (Nano Today) 8:18-26 (2005).
Sanclimens G, Shen H, Giralt E, Albericio F, Saltzman WM, and Royo M. Synthesis and screening of a small library of proline based biodendrimers for use as delivery agents, Peptide Science 80:800-814 (2005).
Gemeinhart RA, Luo D, and Saltzman WM. Cellular fate of a modular DNA delivery system mediated by silica nanoparticles, Biotechnology Progress 21:532-537 (2005). PMID: 15801794
Fahmy TM, Samstein RM, Harness C, and Saltzman WM. Sustained target presentation in biodegradable polymers by surface modification with fatty acid conjugates, Biomaterials 26: 5727-36 (2005).
Tan J, Gemeinhart RA, Ma M, and Saltzman WM. Improved cell adhesion and proliferation on synthetic phosphonic acid-containing hydrogels, Biomaterials, 26: 3663-3671 (2005). PMID: 15621257
Mahoney MJ, Chen R, Tan J, and Saltzman WM. Biomaterials with microchannels influence neurite growth and architecture. Biomaterials 26: 771–778 (2005). PMID: 15350782

Fleming AB, Haverstick KL, and Saltzman WM. In vitro cytotoxicity and in vivo distribution after direct delivery to the rat brain of PEG-camptothecin conjugates. Bioconjugate Chemistry 15:1364-1375 (2004). PMID: 15546204
Keegan ME, Falcone JL, Leung T, and Saltzman WM. Biodegradable microspheres with enhanced capacity for covalently bound surface ligands, Macromolecules 37: 9779-9784 (2004).
Shen H, Tan J, and Saltzman WM. Surface-mediated gene transfer from nanocomposites of controlled texture, Nature Materials, 3: 569-574 (2004). PMID: 15258575
Stroh M, Williams R, Zipfel W, Ma S, Webb WW, and Saltzman WM. Multiphoton microscopy guides neurotrophin modification with poly(ethylene glycol) to enhance interstitial diffusion, Nature Materials 3: 489-494 (2004).
Willits RK and Saltzman WM. The effect of synthetic polymers on the migration of monocytes through human cervical mucus. Biomaterials 25, 4563-4571 (2004).
Luo D, Han E, Belcheva N, and Saltzman WM. A self-assembled, modular DNA delivery system mediated by silica nanoparticles, Journal of Controlled Release 95: 333-341 (2004).
Tan J and Saltzman WM. Biomaterials with hierarchically defined micro- and nano-scale structure. Biomaterials 25: 3593-3601 (2004).
Qian L and Saltzman WM. Improving the expansion and neuronal differentiation of mesenchymal stem cells through culture surface modification. Biomaterials 25:1331-1337 (2004).

Saltzman WM. Cost-reducing protein production and delivery methods for sexually transmitted disease prevention. IEEE Engineering in Medicine and Biology Magazine 22:43-48 (2003).
Shain W, Spartaro L, Dilgen J, Haverstick K, Retterer S, Isaacson M, Saltzman M, and Turner JN. Controlling cellular reactive responses around neural prosthetic dvices using peripheral and local intervention strategies. IEEE Transactions on Neural Systems and Rehabilitation Engineering 11:186-188 (2003).
Keegan ME, Whittum-Hudson JA, and Saltzman WM. Biomimetic design in microparticulate vaccines. Biomaterials 24:4435-4443 (2003).
Chiellini F, Bizzari R, Ober CK, Schmalijohann D, Yu T, Saltzman WM, Solaro R, Chiellini E. Surface patterning and biological evaluation of semi-interpenetrated poly(HEMA)/poly(alkyl beta-malolactonate)s. Macromol. Symp. 197: 369—379 (2003).
Bizzari R, Chiellini F, Ober CK, Saltzman WM, Solaro R, and Chiellini E. Malolactonate polymers and copolymers for biomedical applications. Macromol. Symp. 197: 303-314 (2003).
Stroh M, Zipfel W, Williams RM, Webb WW, and Saltzman WM. Diffusion of nerve growth factor in rat striatum as determined by multiphoton microscopy, Biophysical Journal, 85:581-588 (2003).
Cypes SH, Saltzman WM, Giannelis EP. Organosilicate-polymer drug delivery systems: controlled release and enhanced mechanical properties, Journal of Controlled Release 90:163-169 (2003).
Shen H, Goldberg E, and Saltzman WM. Gene expression and mucosal immune responses after vaginal DNA immunization in mice using a controlled delivery matrix, Journal of Controlled Release 86:339-348 (2003).

Bizzarri R, Chiellini F, Ober CK, Saltzman WM, and Solaro R. Influence of structural parameters on the ring-opening polymerization of new alkyl malolactonate monomers and on the biocompatibility of polymers therefrom, Macromol. Chem. Phys. 203:1684-1693 (2002).
Tan J and Saltzman WM. Topographical control of human neutrophil motility on micropatterned materials with various surface chemistry, Biomaterials, 23: 3215-3225 (2002).
Saltzman WM and Olbricht WL. Building drug delivery into tissue engineering. Nature Reviews Drug Discovery 1:177-186 (2002).
Fleming AB and Saltzman WM. Pharmacokinetics of the carmustine implant, Clinical Pharmacokinetics 41:403-419 (2002).
Luo D, Haverstick K, Belcheva N, Han E, and Saltzman WM. Poly(ethylene glycol)-conjugated dendrimer for biocompatible, high efficient, and low cost DNA delivery, Macromolecules 35:3456-3462 (2002).

Mahoney MJ and Saltzman WM. Transplantation of brain cells assembled around a programmable, synthetic microenvironment. Nature Biotechnology 19:934-938 (2001).
Tan J, Shen H, and Saltzman WM. Micron-scale positioning of features influences the rate of polymorphonuclear leukocyte migration. Biophysical Journal 81:2569-2579 (2001).
Whittum-Hudson JA, Rudy D, Gerard H, Vora G, Davis E, Haller PK, Prattis SM, Hudson AP, Saltzman WM, and Stuart ES. The anti-idiotypic antibody to chlamydial glycolipid exoantigen (GLXA) protects mice against genital infection with a human biovar of Chlamydia trachomatis. Vaccine 19: 4061-71 (2001).
Baldwin SP and Saltzman WM. Aggregation enhances catecholamine synthesis in cultured cells, Tissue Engineering 7:179-190 (2001).
Willits RK and Saltzman WM. Synthetic polymers alter the structure of cervical mucus, Biomaterials 22:445-452 (2001).
Fleming AB and Saltzman WM. Spatially-separated, simultaneous delivery of a protein and protein antagonist can produce sharp boundaries of drug activity, Journal of Controlled Release 70:29-36 (2001).

Saltzman WM. Cell interactions with polymers In Textbook of Tissue Engineering, 2nd edition, RP Lanza, R Langer, J Vacanti (Ed.), Academic Press, NY, p. 221-235 (2000).
Luo D and Saltzman WM. Enhancement of transfection by physical concentration of DNA at the cell surface, Nature Biotechnology, 18: 893-895 (2000).
Tan J, Shen H, Carter KL and Saltzman WM. Controlling human polymorphonuclear leukocyte motility using microfabrication technology, Journal of Biomedical Materials Research 51: 694-702 (2000).
Saltzman WM, Sherwood JK, Adams DR, Castle P, and Haller P. Long-term vaginal antibody delivery: delivery systems and biodistribution, Biotechnology and Bioengineering, 67: 253-264 (2000).
Saltzman WM and Mahoney MJ. Cell structure and motion: a) extracellular matrix and cell adhesion. in Encyclopedia of Animal and Plant Cell Technology, Spier R (Ed.), Wiley, New York, p. 481 to 495 (2000).
Saltzman WM. Interstitial transport in the brain: principles for local drug delivery. Handbook of Biomedical Engineering, Bronzino JD (Ed.), CRC Press, 2nd Edition, p. 99-1 to 99-14 (2000).
Luo D and Saltzman WM. Review: Synthetic DNA delivery systems, Nature Biotechnology 18:33-39 (2000).

Luo D, Woodrow-Mumford K, Belcheva N, and Saltzman WM. Controlled DNA delivery systems, Pharmaceutical Research 16:1300-1308 (1999).
Saltzman WM. Delivering tissue regeneration [commentary], Nature Biotechnology 17:534-535 (1999).
Mahoney MJ and Saltzman WM. Millimeter-scale positioning of a NGF source and biological activity, Proceedings of the National Academy of Sciences 96:4536-4539 (1999).
Tan J and Saltzman WM. Influence of synthetic polymers on neutrophil migration in three-dimensional collagen gels, Journal of Biomedical Materials Research 46:465-474 (1999).
Belcheva N, Woodrow-Mumford K, Mahoney MJ, and Saltzman WM. Synthesis and characterization of polyethylene glycol-mouse nerve growth factor conjugates. Bioconjugate Chemistry, 10: 932-937 (1999).
Saltzman WM, Mak MW, Mahoney MJ, Duenas ET, and Cleland JL. Intracranial delivery of recombinant nerve growth factor: release kinetics and protein distribution for three delivery systems. Pharmaceutical Research 16:232-240 (1999).
Saltzman WM, Livingston TL, and Parkhurst MR. Antibodies to CD18 influence the migration of neutrophils through collagen gels. Journal of Leukocyte Biology: 65:356-363 (1999).
Mahoney MJ and Saltzman WM. Cultures of cells from fetal rat brain: methods to control composition, morphology, and biochemical activity. Biotechnology and Bioengineering: 62:461-467 (1999).
Haller MF and Saltzman WM. Localized delivery of proteins in the brain: Can transport be customized? Pharmaceutical Research 15:377-385 (1998).
Baldwin SP and Saltzman WM. Materials for protein delivery in tissue engineering, Advanced Drug Delivery Reviews 33:71-86 (1998).
Fung LK, Ewend M, Sills A, Sipos EP, Thompson R, Watts M, Colvin OM, Brem H, and Saltzman WM. Pharmacokinetics of interstitial delivery of carmustine, 4-hydroperoxycyclophosphamide and paclitaxel from a biodegradable polymer implant in the monkey brain. Cancer Research 58:672-684 (1998).
Kuo PY, Sherwood JK, and Saltzman WM. Topical antibody delivery systems produce sustained levels in mucosal tissue and blood. Nature Biotechnology 16:163-167 (1998).
Belcheva N, Baldwin S, and Saltzman WM. Synthesis and characterization of polymer-(multi)-peptide conjugates for control of specific cell aggregation, Journal of Biomaterials Science-Polymer Edition 9:207-226 (1998).
Haller MF and Saltzman WM. Growth factor delivery systems, Journal of Controlled Release 53:1-6 (1998).
Wyatt TL, Whaley KJ, Cone RA, and Saltzman WM. Antigen-releasing polymer rings and microspheres stimulate mucosal immunity in the vagina, Journal of Controlled Release 50:93-102 (1998).
Saltzman WM. Weaving cartilage at zero G: the reality of tissue engineering in space [commentary]. Proceedings of the National Academy of Sciences, 94:13380-13382 (1997).
Kuntz RM and Saltzman WM. Polymeric controlled delivery for immunization, Trends in Biotechnology 15:364-369 (1997).
Fung LK and Saltzman WM. Polymeric implants for cancer chemotherapy, Advanced Drug Delivery Reviews 26:209-230 (1997).
Kuntz R and Saltzman WM. Neutrophil motility in extracellular matrix gels: mesh size and adhesion affect speed of migration, Biophysical Journal 72:1472-1480 (1997).
Wyatt TL and Saltzman WM. Protein delivery from non-degradable polymer matrices in Protein Delivery-Physical Systems, Saunders L and Hendren W (Ed.), Plenum Press, New York, p. 119-137 (1997).
Saltzman WM. Growth factor delivery in tissue engineering. MRS Bulletin 21:62-65 (1996).
Krewson CE and Saltzman WM. Nerve growth factor delivery and cell aggregation enhance choline acetyltransferase activity after neural transplantation. Tissue Engineering 2:183-196 (1996).
Mahoney MJ and Saltzman WM, Controlled release of proteins to tissue transplants for the treatment of neurodegenerative disorders, Journal of Pharmaceutical Science 85:1276-1281 (1996).
Whittum-Hudson JA, Prendergast RA, Saltzman WM, An LL, and MacDonald AB. Oral immunization with an anti-idiotypic antibody to the exolipid antigen protects against experimental Chlamydia trachomatis infection, Nature Medicine 2:1116-1122 (1996).
Krewson CE and Saltzman WM. Transport and elimination of recombinant human NGF during long-term delivery to the brain. Brain Research 727:169-181 (1996).
Parkhurst MR and Saltzman WM. Controlled delivery of antibodies against leukocyte adhesion molecules from polymer matrices, Journal of Controlled Release 42:273-288 (1996).
Baldwin SP, Krewson CE, and Saltzman WM. PC12 cell aggregation and neurite growth in gels of collagen, laminin, and fibronectin, International Journal of Developmental Neuroscience 14:351-364 (1996).
Krewson CE, Dause RB, Mak M, and Saltzman WM. Stabilization of nerve growth factor in controlled-release polymers and in tissues, Journal of Biomaterials Science 8:103-117 (1996).
Baldwin SP and Saltzman WM, Polymers for tissue engineering. Trends in Polymer Science 4:177-182 (1996).
Kuo PYP and Saltzman WM. Novel systems for controlled delivery of macromolecules, Critical Reviews in Eukaryotic Gene Expression 6:59-73 (1996).
Fung LK, Shin M, Tyler B, Brem H, and Saltzman WM. Chemotherapeutic drugs released from polymers: Distribution of 1,3-bis(2-chloroethyl)-1-nitrosourea in the rat brain, Pharmaceutical Research 13:671-682 (1996).
Dai W and Saltzman WM. Fibroblast aggregation by suspension with conjugates of poly(ethylene glycol) and RGD, Biotechnology and Bioengineering 50:349-356 (1996).
Sherwood JK, Zeitlin L, Cone RA, and Saltzman WM. Controlled release of antibodies for sustained topical passive immunoprotection of female mice against genital herpes. Nature Biotechnology 14:468-471 (1996).
Saltzman WM. Cell interactions with polymers In Textbook of Tissue Engineering, RP Lanza, WL Chick, and R Langer (Ed.), Springer, NY, p. 227-248 (1996).
Sherwood JK, Zeitlin L, Chen X, Whaley KJ, Cone RA, and Saltzman WM. Residence half time of IgG administered topically to the mouse vagina, Biology of Reproduction 54:264-269 (1996).
Mak M, Fung L, Strasser JF, and Saltzman WM. Distribution of drugs following controlled delivery to the brain interstitium, Journal of Neuro-Oncology 26:91-102 (1995).
Strasser JF, Fung L, Eller S, Grossman SA, and Saltzman WM. Distribution of 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) in the rabbit brain following interstitial delivery by biodegradable polymer implants, Journal of Pharmacology and Experimental Therapeutics 275:1647-1655 (1995).
Krewson CE and Saltzman WM. Targeting of peptides and proteins in the brain following release from implantable polymers in Trends and Future Perspectives in Peptide and Protein Drug Delivery, VHL Lee, M Hasida, and Y Mizushima (Ed.), Harland Academic Publishers, London, p. 273-294 (1995).
Krewson CE, Klarman M, and Saltzman WM. Distribution of nerve growth factor following direct delivery to brain interstitium, Brain Research 680:196-206 (1995).
Saltzman WM, Radomsky ML, Whaley KJ, and Cone RA. Antibody diffusion in human cervical mucus, Biophysical Journal 66:508-515 (1994).
Gutsche AT, Parsons-Wingerter P, Chand D, Saltzman WM, and Leong KW. N-acetylglucosamine and adenosine derivatized surfaces for cell culture: 3T3 fibroblast and chicken hepatocyte response, Biotechnology and Bioengineering 43:801-809 (1994).
Krewson CE, Chung SW, Dai W, and Saltzman WM. Cell aggregation and neurite growth in gels of extracellular matrix molecules, Biotechnology and Bioengineering 43:555-562 (1994).
Dang W, Colvin OM, Brem H, and Saltzman WM. Covalent coupling of methotrexate to dextran enhances the penetration of cytotoxicity into a tissue-like matrix, Cancer Research 54:1729-1735 (1994).
Parkhurst MR and Saltzman WM, Leukocytes migrate in three-dimensional gels of midcycle cervical mucus, Cellular Immunology 156:77-94 (1994).
Dang W and Saltzman WM. Controlled release of macromolecules from a biodegradable polyanhydride matrix, Journal of Biomaterials Science 6:297-311 (1994).
Salehi-Had S and Saltzman WM. Controlled intracranial delivery of antibodies in the rat in Protein Formulations and Delivery, J. Cleland and R. Langer (Ed.), ACS Symposium Series 567:278-291 (1994).
Dai W, Belt J, and Saltzman WM. Cell-binding peptides conjugated to poly(ethylene glycol) promote neural cell aggregation, Bio/Technology 12:797-801 (1994).
Beaty CE and Saltzman WM. Controlled growth factor delivery induces differential neurite outgrowth in three-dimensional cell cultures. Journal of Controlled Release 24:15-23 (1993).
Saltzman WM, Sheppard NF, McHugh MA, Dause R, Pratt JA, Dodrill AM. Controlled antibody release from a matrix of poly(ethylene-co-vinyl acetate) fractionated with a supercritical fluid. Journal of Applied Polymer Science 48:1493-1500 (1993).
Saltzman WM. Antibodies for treating and preventing disease: the potential role of polymeric controlled release. Critical Reviews in Therapeutic Drug Carrier Systems 10:111-142 (1993).
Parsons-Wingerter P and Saltzman WM. Growth versus function in three-dimensional culture of single and aggregated hepatocytes within collagen gels. Biotechnology Progress 9:600-607 (1993).
Saltzman WM, Parkhurst MR, Parsons-Wingerter P, and Zhu W.-H. Three-dimensional cell cultures mimic tissues. Annals of the New York Academy of Sciences 665:259-273 (1992).
Parkhurst MR and Saltzman WM. Quantification of human neutrophil motility in three-dimensional collagen gels: effect of collagen concentration. Biophysical Journal 61:306-315 (1992).
Radomsky ML, Whaley KJ, Cone RA, and Saltzman WM. Controlled vaginal delivery of antibodies in the mouse, Biology of Reproduction 47:133-140 (1992).
Dang W and Saltzman WM. Dextran retention in the rat brain following release from a polymer implant. Biotechnology Progress 8:527-532 (1992).
Sherwood JK, Dause R, and Saltzman WM. Controlled antibody delivery systems, Bio/Technology 10:1446-1449 (1992).
Saltzman WM, Parsons-Wingerter P, Leong KW, and Lin S, Fibroblast and hepatocyte behavior on synthetic polymer surfaces. Journal of Biomedical Materials Research 25:741-759 (1991).
Saltzman WM and Tena L. Spermicide permeation through biocompatible polymers. Contraception 43:497-505 (1991).
Saltzman WM and Radomsky ML. Molecules released from polymers: diffusion and elimination from brain tissue, Chemical Engineering Science 46:2429-2444 (1991).
Reinhard CS, Radomsky ML, Saltzman WM, Hilton J and Brem H. Polymeric controlled release of dexamethasone in normal rat brain. Journal of Controlled Release 16:331-340 (1991).
Powell EM, Sobarzo MR, and Saltzman WM. Controlled release of nerve growth factor from a polymeric implant, Brain Research 515:309-311 (1990).
Saltzman WM. Transport in porous polymers, in Absorbent Polymer Technology, L. Brannon-Peppas and R.S. Harland (Eds.), Elsevier, Amsterdam, 171-199 (1990).
Radomsky ML, Whaley K, Cone RA, and Saltzman WM. Macromolecules released from polymers: Diffusion into unstirred fluids. Biomaterials 11:619-624 (1990).
Zydney AL, Saltzman WM, and Colton CK. The hydraulic resistance of red cell beds in an unstirred filtration cell, Chemical Engineering Science 44:147-159 (1989).
Freese A, Sabel BA, Saltzman WM, During MJ, and Langer R. Controlled release of dopamine from a polymeric brain implant: in vitro characterization, Experimental Neurology 103:234-238 (1989).
Saltzman WM and Langer R. Transport rates of proteins in porous polymers with known microgeometry, Biophysical Journal 55:163-171 (1989).
During MJ, Sabel BA, Freese A, Saltzman WM, Deutz A, Roth RH, and Langer R. Controlled release of dopamine from a polymeric brain implant: in vivo characterization, Annals of Neurology 25:351-356 (1989).
Mathiowitz E, Saltzman WM, Domb A, Dor P, and Langer R. Polyanhydride microspheres as drug carriers. II. Microencapsulation by solvent removal, Journal of Applied Polymer Science 35:755-774 (1988).
Vacanti JP, Morse M, Domb A, Saltzman WM, Perez-Atayde A, and Langer R. Selective cell transplantation using bioabsorbable artificial polymers as matrices, Journal of Pediatric Surgery 23:3-9 (1988).
Mullon C, Saltzman WM, and Langer R. A new method for computer assisted visualization and analysis of the distribution of matrix-bound proteins, Bio/Technology 6:927-929 (1988).
Saltzman WM, Pasternak SH and Langer R. Quantitative image analysis for developing microstructural descriptions of heterogeneous materials, Chemical Engineering Science 42: 1989-2001 (1987).
Saltzman WM, Pasternak SH, and Langer R. Microstructural models for diffusive transport in porous polymers in Recent Advances in Controlled Release Technology, ACS Symposium Series 348, P.I. Lee and W.R. Good (Ed.), pp 17-31 (1987).

Saltzman WM, Biomedical Engineering: Bridging Medicine and Technology, Cambridge University Press (2009).
Saltzman WM, Tissue Engineering: Principles for the design of replacement organs and tissues, Oxford University Press (2004).
Saltzman WM, Drug Delivery: Engineering principles for drug therapy, Oxford University Press (2001).

Saltzman WM, Brandsma J, and Shen H (Editors), DNA Vaccines, Methods in Molecular Medicine series, Humana Press (2006).
Luo D and Saltzman WM (Editors), Synthetic DNA Delivery Systems, Landes Publishing (2003).

Publication History

Research Interests

Contact

For More Information